This contract expires in 110 days (Sep 30, 2026).

Browse related active opportunities

FIRM FIXED PRICE

PROGENICS PHARMACEUTICALS INC - PYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.:1106332 [26-000012]

PIID: 75N90026F00006Solicitation ID: NOI-CC-26-000012
Signed Date: Dec 16, 2025Effective Date: Oct 1, 2025End Date: Closes in 110 days
Award $
$163K
Vendor
PROGENICS PHARMACEUTICALS INC
NAICS
325412
Signed Date
Dec 16, 2025

Key Details

Dollars Obligated
$163,192.4
Base & All Options
$348,837.12
Awarding Sub-Agency
National Institutes of Health
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
NORTH BILLERICA, MA, 018622849, CD-MA-03

Description

PYLARIFY (PIFLUFOLASTAT F-18) FROM PROGENICS PHARMACEUTICALS INC.:1106332 [26-000012]

Context & Analysis

On Dec 16, 2025, Department of Health and Human Services obligated $163,192.4 to PROGENICS PHARMACEUTICALS INC for pylarify (piflufolastat f-18) from progenics pharmaceuticals inc.:1106332 [26-000012]. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in NORTH BILLERICA, MA. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325412 — related awards are listed below.

Contractor Information

UEI: YLYKVRPCTCR3
CAGE Code: 34KE9
Location: NORTH BILLERICA, MA
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related